Ariad Pharmaceuticals Inc fka ARIA

[DonShimoda]

So true. Anyone who is waiting for the gap to fill or listened to the tripe about being range bound for months is missing the boat. I'm expecting news every 4 to 6 weeks from now until the end of the year...and beyond.

Next up:

AACR presentation (April)
ASCO Abstracts (May)
ASCO presentation (June)
RIDA NDA (Summer)
Milestone payments (Summer)
AP113 P1 trial start (Summer/Fall)
Ponatinib First look/Full enrollment - ASH (Fall/Winter)
New Rida trials???
Ponatinib partnering???
Rida Approval???
Ponatinib NDA???

Per BTH - Phase 3 endometrial study to begin and initiation of further Phase 2 / 3 combination trials.

Per biotech_researcher - "the release of information on new indications for all three of their compounds. Today, we just had the release for the pan-FGFR inhibitor for Pona, which is one. '113 will have one beyond NSCLC, and Rida will have another